4.6 Review

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus

期刊

VIRUSES-BASEL
卷 12, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/v12080826

关键词

Hepatitis E virus; ORF2 capsid protein; HEV VLPs; vaccines

类别

向作者/读者索取更多资源

Hepatitis E virus (HEV), a pathogen that causes acute viral hepatitis, is a small icosahedral, quasi-enveloped, positive ssRNA virus. Its genome has three open reading frames (ORFs), withORF1andORF3encoding for nonstructural and regulatory proteins, respectively, whileORF2is translated into the structural, capsid protein.ORF2is most widely used for vaccine development in viral hepatitis. Hepatitis E virus-like particles (VLPs) are potential vaccine candidates against HEV infection. VLPs are composed of capsid subunits mimicking the natural configuration of the native virus but lack the genetic material needed for replication. As a result, VLPs are unable to replicate and cause disease, constituting safe vaccine platforms. Currently, the recombinant VLP-based vaccine Hecolin(R)against HEV is only licensed in China. Herein, systematic information about the expression of various HEVORF2sequences and their ability to form VLPs in different systems is provided.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据